RadFollow
Sign in
Guideline Current IAP 2017

Fukuoka / International Consensus IPMN Guidelines

International consensus guidelines for management of pancreatic IPMN and MCN. Stratifies cysts by high-risk stigmata, worrisome features, main duct diameter, and cyst size.

Structured reportUpdated Jul 5, 2026
Applies to
  • Adults with incidentally detected pancreatic cystic lesions
  • IPMN and MCN evaluation on CT or MRI/MRCP
Classification
  • Feature group High-risk stigmata
  • Feature group Worrisome features
  • Feature group Neither
Exclusions
  • Known pancreatic adenocarcinoma
  • Pseudocysts
  • Serous cystadenoma with classic imaging
Interactive

Decision tree

Enter a finding to compute a recommendation without leaving the page.

Recommendation builder

Category is derived: high-risk stigmata → resection; worrisome features → EUS; otherwise surveillance interval by cyst size.

Evidence

References

  1. PrimaryTanaka M, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738-753.
FAQ

Frequently asked

Does this guideline apply to oncology patients?

No — patients with known malignancy fall outside the scope unless the guideline states otherwise. Follow oncologic surveillance protocols instead.